Condition: Benign Prostatic Hyperplasia · Sponsor: Rivermark Medical
The goal of this study is to determine the safety and effectiveness of the FloStent, a medical device used to treat men with symptoms of Benign Prostatic Hyperplasia, compared to sham (procedure without deployment of the FloStent). All participants will undergo a flexible cystoscopy and those randomized to the treatment arm will receive the FloStent, while those randomized to the sham arm will not receive the FloStent.
This description comes directly from the study's public registry record.
Study Manager Study Director, MD · 414-758-7948 · info@rivermarkmedical.com
Always discuss trial participation with your own doctor first.
| Michael G Oefelein Clinical Trials | Bakersfield, California, United States | Recruiting |
| Comprehensive Urology Medical Group | Beverly Hills, California, United States | Recruiting |
| Atlas Men's Health | La Mesa, California, United States | Recruiting |
| Urology Group of Southern California | Los Angeles, California, United States | Recruiting |
| Alarcon Urology Center | Montebello, California, United States | Recruiting |
| Prestige Medical Group | Tustin, California, United States | Recruiting |
| Urology Denver | Littleton, Colorado, United States | Recruiting |
| Advanced Urology Institute | Daytona Beach, Florida, United States | Recruiting |
| Duly Health | Lisle, Illinois, United States | Recruiting |
| Southern Urology | Lafayette, Louisiana, United States | Recruiting |
| Michigan Institute of Urology | Troy, Michigan, United States | Recruiting |
| Sheldon Freedman Urology | Las Vegas, Nevada, United States | Recruiting |
+ 8 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06849258